President Donald Trump vowed to impose tariffs on pharmaceuticals within two weeks. Eli Lilly, a leader in the industry, could be harmed by the move, but it is already preparing for it.

Despite beating on its earnings Thursday, pharma giant Eli Lilly (LLY) suffered a nearly 12% loss in its stock, losing more than $90 billion in market cap in a single day. "We think the market ...

Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy ...

That could be bad news for leaders in this sector, including Eli Lilly (NYSE: LLY), the largest pharmaceutical company in the world by market cap. Should investors give up on the stock?

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

INDIANAPOLIS — Indianapolis-based pharmaceutical giant Eli Lilly and Company will invest up to $250 million as part of an expanded partnership with Purdue University announced Friday, May 9. The ...

Pharmaceutical giant Eli Lilly and Co. on Friday announced plans to invest up to $250 million with Purdue over the next eight years, aiming to fast-track drug development and boost Indiana’s ...

INDIANAPOLIS — Over the next eight years, Eli Lilly and Company and Purdue University will continue their partnership. According to an announcement on Friday morning, Lilly is expected to invest ...